ask="1.450"
ask_size="1000"
average_daily_volume="777326"
bid="1.350"
bid_size="1100"
book_value="1.373"
change="-0.025"
change_from_200_day_moving_average="-1.491"
change_from_50_day_moving_average="-0.808"
change_from_52_week_high="-7.525"
change_From_52_week_low="0.325"
change_in_percent="-1.786%"
close="1.375"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.310"
ebitda="-61.52M"
eps_estimate_current_year="-1.490"
eps_estimate_next_quarter="-0.370"
eps_estimate_next_year="-1.350"
ex_dividend_date="N/A"
float_shares="36032000"
high="1.450"
high_52_weeks="8.900"
last_trade_date="2/7/2017"
last_trade_price="1.375"
last_trade_size="4598"
last_trade_time="4:00pm"
low="1.350"
low_52_weeks="1.050"
market_capitalization="72.77M"
moving_average_200_day="2.866"
moving_average_50_day="2.183"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="7.000"
open="1.350"
pe_ratio="N/A"
peg_ratio="-0.020"
percent_change_from_200_day_moving_average="-52.025%"
percent_change_from_50_day_moving_average="-37.017%"
percent_change_from_52_week_high="-84.551%"
percent_change_from_52_week_low="+30.952%"
previous_close="1.400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.020"
price_per_sales="6.156"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="4.530"
stock_exchange="NGM"
symbol="RGLS"
volume="486462"
weeks_range_52="1.050 - 8.900"
